Cullinan Therapeutics, Inc. - COM (CGEM)

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
1.39 M
Holdings value Q1 2024
$23.6 M
Value change Q1 2024
-$9.43 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
4
Number of buys Q1 2024
3
Number of sells Q1 2024
-19
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
230031106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 1.39 M $23.6 M -$9.43 M $17.04 4
2023 Q4 35.9 M $366 M +$20.5 M $10.19 109
2023 Q3 38 M $344 M +$11 M $9.05 104
2023 Q2 36.7 M $395 M +$48.7 M $10.76 102
2023 Q1 32.2 M $329 M -$56.4 M $10.23 96
2022 Q4 37.7 M $398 M +$5.32 M $10.55 92
2022 Q3 36.7 M $471 M -$6.34 M $12.82 90
2022 Q2 36.9 M $473 M +$22.1 M $12.82 76
2022 Q1 36.8 M $385 M +$4.83 M $10.47 74
2021 Q4 36 M $554 M +$2.28 M $15.43 72
2021 Q3 33.9 M $762 M +$33.7 M $22.57 64
2021 Q2 32.3 M $829 M -$17.6 M $25.75 70
2021 Q1 31.3 M $1.3 B +$1.3 B $41.67 70